| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.0M | — |
| R&D Expense | $26.1M | -6.0% |
| SG&A Expense | $12.8M | -0.8% |
| Operating Income | -$29.9M | +24.1% |
| Net Income | -$29.9M | +28.5% |
| EPS (Basic) | -$3.58 | -550.9% |
| EPS (Diluted) | -$3.58 | -550.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.8M | -72.2% |
| Current Assets | $16.6M | -63.9% |
| Total Assets | $34.4M | -49.5% |
| Current Liabilities | $7.8M | -39.7% |
| Total Liabilities | $14.8M | -38.6% |
| Stockholders' Equity | $19.6M | -55.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.0M | +1.1% |
| Investing Cash Flow | -$4.9M | -57.9% |
| Financing Cash Flow | $202K | -99.6% |